NCT00408616View on ClinicalTrials.gov

Efficacy and Safety of Grazax in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

253

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

November 30, 2007

Conditions
Allergy
Interventions
BIOLOGICAL

Grazax-R

Grass tablet, 75.000 SQ per day for one year

BIOLOGICAL

Grazax Placebo

Grazax Placebo, 0 SQ tablet per day for one year

Trial Locations (1)

22415

Tangstedter Landstrasse 77, Hamburg

All Listed Sponsors
lead

ALK-Abelló A/S

INDUSTRY

NCT00408616 - Efficacy and Safety of Grazax in Children | Biotech Hunter | Biotech Hunter